English | Español
Patient Daily | Mar 11, 2026

FDA stands firm on sham-controlled trial requirement for uniQure's Huntington's therapy
Patient Daily | Mar 11, 2026

Johnson & Johnson receives rapid FDA approval for new multiple myeloma combination
Patient Daily | Mar 11, 2026

Roche and Zealand Pharma report mixed mid-stage results for obesity drug
Patient Daily | Mar 11, 2026

Direct-to-consumer drug sales offer limited relief for high medication costs
Patient Daily | Mar 11, 2026

Cornell study finds adult microbe exposure may worsen some allergies
Patient Daily | Mar 11, 2026

UCLA study links parental brain circuits to social support behaviors in mice
Patient Daily | Mar 11, 2026

Yale study finds many seniors improve mentally or physically with positive outlooks
Patient Daily | Mar 11, 2026

Study shows unconscious memory reactivation may inform new dementia treatments

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug